Economic portfolio
Mirae Asset Nifty 500 Healthcare ETF
MIRAE Mirae Asset Mutual Fund Apr 2026 — Sep 2026 6 months
Data periodFund holdingsSep 2026NSE prices23 Oct 2026Data status →
Days to sell half: 0.0 — selling half of every holding at 20% of each stock’s usual daily NSE trading, the time to get through 90% of the portfolio (Sep 2026). Quick to unwind on normal volumes. Small-cap comparison →
Shares of this fund’s disclosed Indian listed equity, valued at official NSE closing prices. Cash, debt, derivatives and overseas holdings are not included, so for a hybrid or debt fund these are shares of its equity part only. Not performance, and not a recommendation.
How concentrated it has been
6 priced months, Apr 2026 to Sep 2026 · at each month’s NSE closes
Top 10 holdings, share of equity
59.5% now · highest 59.5%, lowest 57.0%
Companies held
44 now · largest single holding 10.1% of equity
Sector mix
Share of the equity shown · NSE industry
Funds most like this one
Overlap of disclosed equity · the smaller share of each company both hold, added up
- Bandhan BSE Healthcare Index FundBandhan · 44 shared85.2%
- Motilal Oswal BSE Healthcare ETFMotilal Oswal · 44 shared85.2%
- EODWHFEdelweiss · 25 shared83.7%
- DSP Nifty Healthcare ETFDSP · 20 shared79.8%
- ICICI Prudential Nifty Healthcare ETFICICI Prudential · 20 shared79.8%
- ADITYA BIRLA SUN LIFE NIFTY HEALTHCARE ETFAditya Birla Sun Life · 20 shared79.8%
- Axis NIFTY Healthcare ETFAxis · 20 shared79.8%
- DSP Nifty Healthcare Index FundDSP · 20 shared79.8%
Select one to see exactly what the two funds share. Index funds and ETFs tracking the same index overlap almost completely.
What changed in Sep 2026
This portfolio’s consecutive disclosures · evidenced adjustments applied
New positions
Complete exits
Largest increases
- 01 Sun Pharmaceutical Industries Limited+13.9% +1,049
- 02 Max Healthcare Institute Limited+6.5% +519
- 03 Dr. Reddy's Laboratories Limited+6.6% +429
- 04 Piramal Pharma Limited+6.4% +425
- 05 Cipla Limited+6.5% +394
- 06 Fortis Healthcare Limited+6.5% +363
- 07 Biocon Limited+4.0% +309
- 08 Anthem Biosciences Limited+29.1% +277
- 09 Laurus Labs Limited+6.6% +276
- 10 Krishna Institute of Medical Sciences Limited+9.7% +268
Largest reductions
- None this month.
Share quantities, not market values or cash flows.
Holdings by value
Sep 2026 · largest 100 · share of the equity shown
| Company | Sector | Size | Share of equity | Value | Shares held | Held since |
|---|---|---|---|---|---|---|
| Sun Pharmaceutical Industries Limited | Healthcare | Large Cap | 10.14% | 1.56 Cr | 8,570 | by Apr 2026 (6 mo+) |
| Divi's Laboratories Limited | Healthcare | Large Cap | 8.76% | 1.35 Cr | 1,448 | by Apr 2026 (6 mo+) |
| Apollo Hospitals Enterprise Limited | Healthcare | Large Cap | 6.24% | 0.96 Cr | 1,173 | by Apr 2026 (6 mo+) |
| Laurus Labs Limited | Healthcare | Mid Cap | 5.72% | 0.88 Cr | 4,437 | by Apr 2026 (6 mo+) |
| Cipla Limited | Healthcare | Large Cap | 5.62% | 0.86 Cr | 6,412 | by Apr 2026 (6 mo+) |
| Dr. Reddy's Laboratories Limited | Healthcare | Large Cap | 5.58% | 0.86 Cr | 6,949 | by Apr 2026 (6 mo+) |
| Torrent Pharmaceuticals Limited | Healthcare | Large Cap | 5.24% | 0.80 Cr | 1,676 | by Apr 2026 (6 mo+) |
| Max Healthcare Institute Limited | Healthcare | Large Cap | 5.13% | 0.79 Cr | 8,479 | by Apr 2026 (6 mo+) |
| Lupin Limited | Healthcare | Mid Cap | 3.66% | 0.56 Cr | 2,767 | by Apr 2026 (6 mo+) |
| Aurobindo Pharma Limited | Healthcare | Mid Cap | 3.43% | 0.53 Cr | 3,148 | by Apr 2026 (6 mo+) |
| Fortis Healthcare Limited | Healthcare | Mid Cap | 2.98% | 0.46 Cr | 5,936 | by Apr 2026 (6 mo+) |
| Glenmark Pharmaceuticals Limited | Healthcare | Mid Cap | 2.61% | 0.40 Cr | 1,716 | by Apr 2026 (6 mo+) |
| Alkem Laboratories Limited | Healthcare | Mid Cap | 2.31% | 0.35 Cr | 687 | by Apr 2026 (6 mo+) |
| Zydus Lifesciences Limited | Healthcare | Mid Cap | 2.14% | 0.33 Cr | 2,823 | by Apr 2026 (6 mo+) |
| Mankind Pharma Limited | Healthcare | Mid Cap | 2.10% | 0.32 Cr | 1,291 | by Apr 2026 (6 mo+) |
| IPCA Laboratories Limited | Healthcare | Mid Cap | 1.99% | 0.30 Cr | 1,582 | by Apr 2026 (6 mo+) |
| Biocon Limited | Healthcare | Mid Cap | 1.91% | 0.29 Cr | 7,940 | by Apr 2026 (6 mo+) |
| Gland Pharma Limited | Healthcare | Small Cap | 1.71% | 0.26 Cr | 908 | by Apr 2026 (6 mo+) |
| Sai Life Sciences Limited | Healthcare | Small Cap | 1.56% | 0.24 Cr | 1,575 | by Apr 2026 (6 mo+) |
| Krishna Institute of Medical Sciences Limited | Healthcare | Small Cap | 1.48% | 0.23 Cr | 3,040 | by Apr 2026 (6 mo+) |
| Aster DM Quality Care Limited | Healthcare | Small Cap | 1.38% | 0.21 Cr | 3,045 | by Apr 2026 (6 mo+) |
| Neuland Laboratories Limited | Healthcare | Small Cap | 1.36% | 0.21 Cr | 98 | by Apr 2026 (6 mo+) |
| Wockhardt Limited | Healthcare | Small Cap | 1.30% | 0.20 Cr | 941 | by Apr 2026 (6 mo+) |
| Acutaas Chemicals Limited | Healthcare | Small Cap | 1.26% | 0.19 Cr | 591 | by Apr 2026 (6 mo+) |
| Ajanta Pharma Limited | Healthcare | Small Cap | 1.22% | 0.19 Cr | 519 | by Apr 2026 (6 mo+) |
| Dr. Lal Path Labs Ltd. | Healthcare | Small Cap | 1.15% | 0.18 Cr | 889 | by Apr 2026 (6 mo+) |
| Abbott India Limited | Healthcare | Mid Cap | 1.04% | 0.16 Cr | 59 | by Apr 2026 (6 mo+) |
| Piramal Pharma Limited | Healthcare | Small Cap | 0.95% | 0.15 Cr | 7,077 | by Apr 2026 (6 mo+) |
| Granules India Limited | Healthcare | Small Cap | 0.93% | 0.14 Cr | 1,680 | by Apr 2026 (6 mo+) |
| Narayana Hrudayalaya Ltd. | Healthcare | Mid Cap | 0.92% | 0.14 Cr | 787 | by Apr 2026 (6 mo+) |
| Global Health Limited | Healthcare | Mid Cap | 0.90% | 0.14 Cr | 1,009 | by Apr 2026 (6 mo+) |
| Onesource Specialty Pharma Limited | Healthcare | Small Cap | 0.89% | 0.14 Cr | 896 | by Apr 2026 (6 mo+) |
| GlaxoSmithKline Pharmaceuticals Limited | Healthcare | Mid Cap | 0.85% | 0.13 Cr | 471 | by Apr 2026 (6 mo+) |
| Anthem Biosciences Limited | Healthcare | Mid Cap | 0.69% | 0.11 Cr | 1,229 | by Apr 2026 (6 mo+) |
| Emcure Pharmaceuticals Limited | Healthcare | Small Cap | 0.60% | 0.09 Cr | 476 | by Apr 2026 (6 mo+) |
| Natco Pharma Limited | Healthcare | Small Cap | 0.55% | 0.08 Cr | 1,024 | by Apr 2026 (6 mo+) |
| Cohance Lifesciences Limited | Healthcare | Small Cap | 0.54% | 0.08 Cr | 1,853 | by Apr 2026 (6 mo+) |
| Vijaya Diagnostic Centre Limited | Healthcare | Small Cap | 0.52% | 0.08 Cr | 558 | by Apr 2026 (6 mo+) |
| Syngene International Limited | Healthcare | Small Cap | 0.51% | 0.08 Cr | 2,163 | by Apr 2026 (6 mo+) |
| Rainbow Childrens Medicare Limited | Healthcare | Small Cap | 0.49% | 0.07 Cr | 567 | by Apr 2026 (6 mo+) |
| Poly Medicure Limited | Healthcare | Small Cap | 0.47% | 0.07 Cr | 435 | by Apr 2026 (6 mo+) |
| Rubicon Research Limited | Healthcare | Small Cap | 0.43% | 0.07 Cr | 405 | Sep 2026 (1 mo) |
| Caplin Point Laboratories Limited | Healthcare | Small Cap | 0.40% | 0.06 Cr | 228 | by Apr 2026 (6 mo+) |
| Concord Biotech Limited | Healthcare | Small Cap | 0.34% | 0.05 Cr | 376 | by Apr 2026 (6 mo+) |
Half of its current holdings have been held for 6 disclosed months or more without a break. “By” means held in the first month we have for this fund, so possibly for longer. Counted over this fund’s own monthly disclosures; a merger (e.g. HDFC into HDFC Bank, July 2023) starts a new run for the surviving company.
Recent position changes
Latest 100 company-month records · evidenced adjustments applied
| Company | Month | Activity | Adjusted change |
|---|---|---|---|
| Indegene Limited | Sep 2026 | ▼ Complete exit | -1,106 |
| Sun Pharmaceutical Industries Limited | Sep 2026 | ▲ Increasing | +1,049 |
| Jubilant Pharmova Limited | Sep 2026 | ▼ Complete exit | -861 |
| Eris Lifesciences Limited | Sep 2026 | ▼ Complete exit | -577 |
| Blue Jet Healthcare Limited | Sep 2026 | ▼ Complete exit | -545 |
| Max Healthcare Institute Limited | Sep 2026 | ▲ Increasing | +519 |
| Dr. Reddy's Laboratories Limited | Sep 2026 | ▲ Increasing | +429 |
| Piramal Pharma Limited | Sep 2026 | ▲ Increasing | +425 |
| Rubicon Research Limited | Sep 2026 | ▲ New position | +405 |
| Cipla Limited | Sep 2026 | ▲ Increasing | +394 |
| Fortis Healthcare Limited | Sep 2026 | ▲ Increasing | +363 |
| Biocon Limited | Sep 2026 | ▲ Increasing | +309 |
| Anthem Biosciences Limited | Sep 2026 | ▲ Increasing | +277 |
| Laurus Labs Limited | Sep 2026 | ▲ Increasing | +276 |
| Krishna Institute of Medical Sciences Limited | Sep 2026 | ▲ Increasing | +268 |
| Aurobindo Pharma Limited | Sep 2026 | ▲ Increasing | +188 |
| Aster DM Quality Care Limited | Sep 2026 | ▲ Increasing | +186 |
| Lupin Limited | Sep 2026 | ▲ Increasing | +169 |
| Pfizer Limited | Sep 2026 | ▼ Complete exit | -162 |
| Zydus Lifesciences Limited | Sep 2026 | ▲ Increasing | +147 |
| Syngene International Limited | Sep 2026 | ▲ Increasing | +130 |
| Granules India Limited | Sep 2026 | ▲ Increasing | +128 |
| Cohance Lifesciences Limited | Sep 2026 | ▲ Increasing | +113 |
| Emcure Pharmaceuticals Limited | Sep 2026 | ▲ Increasing | +109 |
| Torrent Pharmaceuticals Limited | Sep 2026 | ▲ Increasing | +108 |
| Glenmark Pharmaceuticals Limited | Sep 2026 | ▲ Increasing | +106 |
| Sai Life Sciences Limited | Sep 2026 | ▲ Increasing | +100 |
| IPCA Laboratories Limited | Sep 2026 | ▲ Increasing | +97 |
| Global Health Limited | Sep 2026 | ▲ Increasing | +94 |
| Divi's Laboratories Limited | Sep 2026 | ▲ Increasing | +89 |
| Mankind Pharma Limited | Sep 2026 | ▲ Increasing | +81 |
| Apollo Hospitals Enterprise Limited | Sep 2026 | ▲ Increasing | +72 |
| Ajanta Pharma Limited | Sep 2026 | ▲ Increasing | +68 |
| Natco Pharma Limited | Sep 2026 | ▲ Increasing | +64 |
| Alkem Laboratories Limited | Sep 2026 | ▲ Increasing | +62 |
| Wockhardt Limited | Sep 2026 | ▲ Increasing | +58 |
| Dr. Lal Path Labs Ltd. | Sep 2026 | ▲ Increasing | +56 |
| Gland Pharma Limited | Sep 2026 | ▲ Increasing | +56 |
| Onesource Specialty Pharma Limited | Sep 2026 | ▲ Increasing | +55 |
| Narayana Hrudayalaya Ltd. | Sep 2026 | ▲ Increasing | +48 |
| Acutaas Chemicals Limited | Sep 2026 | ▲ Increasing | +37 |
| Vijaya Diagnostic Centre Limited | Sep 2026 | ▲ Increasing | +34 |
| Rainbow Childrens Medicare Limited | Sep 2026 | ▲ Increasing | +34 |
| GlaxoSmithKline Pharmaceuticals Limited | Sep 2026 | ▲ Increasing | +29 |
| Poly Medicure Limited | Sep 2026 | ▲ Increasing | +26 |
| Concord Biotech Limited | Sep 2026 | ▲ Increasing | +21 |
| Caplin Point Laboratories Limited | Sep 2026 | ▲ Increasing | +15 |
| Neuland Laboratories Limited | Sep 2026 | ▲ Increasing | +6 |
| Abbott India Limited | Sep 2026 | ▲ Increasing | +4 |
| Max Healthcare Institute Limited | Aug 2026 | ▲ Increasing | +471 |
| Biocon Limited | Aug 2026 | ▲ Increasing | +452 |
| Sun Pharmaceutical Industries Limited | Aug 2026 | ▲ Increasing | +445 |
| Piramal Pharma Limited | Aug 2026 | ▲ Increasing | +393 |
| Dr. Reddy's Laboratories Limited | Aug 2026 | ▲ Increasing | +386 |
| Cipla Limited | Aug 2026 | ▲ Increasing | +356 |
| Fortis Healthcare Limited | Aug 2026 | ▲ Increasing | +329 |
| Aster DM Quality Care Limited | Aug 2026 | ▲ Increasing | +312 |
| Laurus Labs Limited | Aug 2026 | ▲ Increasing | +246 |
| Aurobindo Pharma Limited | Aug 2026 | ▲ Increasing | +175 |
| Krishna Institute of Medical Sciences Limited | Aug 2026 | ▲ Increasing | +164 |
| Zydus Lifesciences Limited | Aug 2026 | ▲ Increasing | +158 |
| Lupin Limited | Aug 2026 | ▲ Increasing | +154 |
| Syngene International Limited | Aug 2026 | ▲ Increasing | +120 |
| Cohance Lifesciences Limited | Aug 2026 | ▲ Increasing | +103 |
| Glenmark Pharmaceuticals Limited | Aug 2026 | ▲ Increasing | +95 |
| Torrent Pharmaceuticals Limited | Aug 2026 | ▲ Increasing | +92 |
| Granules India Limited | Aug 2026 | ▲ Increasing | +92 |
| IPCA Laboratories Limited | Aug 2026 | ▲ Increasing | +88 |
| Sai Life Sciences Limited | Aug 2026 | ▲ Increasing | +87 |
| Divi's Laboratories Limited | Aug 2026 | ▲ Increasing | +80 |
| Mankind Pharma Limited | Aug 2026 | ▲ Increasing | +71 |
| Indegene Limited | Aug 2026 | ▲ Increasing | +66 |
| Apollo Hospitals Enterprise Limited | Aug 2026 | ▲ Increasing | +65 |
| Anthem Biosciences Limited | Aug 2026 | ▲ Increasing | +57 |
| Natco Pharma Limited | Aug 2026 | ▲ Increasing | +56 |
| Global Health Limited | Aug 2026 | ▲ Increasing | +54 |
| Wockhardt Limited | Aug 2026 | ▲ Increasing | +52 |
| Jubilant Pharmova Limited | Aug 2026 | ▲ Increasing | +51 |
| Gland Pharma Limited | Aug 2026 | ▲ Increasing | +50 |
| Onesource Specialty Pharma Limited | Aug 2026 | ▲ Increasing | +50 |
| Dr. Lal Path Labs Ltd. | Aug 2026 | ▲ Increasing | +49 |
| Narayana Hrudayalaya Ltd. | Aug 2026 | ▲ Increasing | +44 |
| Alkem Laboratories Limited | Aug 2026 | ▲ Increasing | +37 |
| Eris Lifesciences Limited | Aug 2026 | ▲ Increasing | +34 |
| Acutaas Chemicals Limited | Aug 2026 | ▲ Increasing | +33 |
| Blue Jet Healthcare Limited | Aug 2026 | ▲ Increasing | +33 |
| Rainbow Childrens Medicare Limited | Aug 2026 | ▲ Increasing | +32 |
| Vijaya Diagnostic Centre Limited | Aug 2026 | ▲ Increasing | +31 |
| Ajanta Pharma Limited | Aug 2026 | ▲ Increasing | +27 |
| GlaxoSmithKline Pharmaceuticals Limited | Aug 2026 | ▲ Increasing | +26 |
| Poly Medicure Limited | Aug 2026 | ▲ Increasing | +25 |
| Concord Biotech Limited | Aug 2026 | ▲ Increasing | +21 |
| Emcure Pharmaceuticals Limited | Aug 2026 | ▲ Increasing | +21 |
| Caplin Point Laboratories Limited | Aug 2026 | ▲ Increasing | +12 |
| Pfizer Limited | Aug 2026 | ▲ Increasing | +10 |
| Neuland Laboratories Limited | Aug 2026 | ▲ Increasing | +6 |
| Abbott India Limited | Aug 2026 | ▲ Increasing | +3 |
| J.B. Chemicals & Pharmaceuticals Lt | Jul 2026 | ▼ Complete exit | -823 |
| Torrent Pharmaceuticals Limited | Jul 2026 | ▲ Increasing | +420 |
| Blue Jet Healthcare Limited | Jul 2026 | ▲ Increasing | +159 |
Changes compare consecutive month-end disclosures for this portfolio only.